Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Inter-recti distance |
Inter-recti distance will be measured by ultrasonography at rest, during abdominal draw-in and abdominal curl-up, at 2 locations on the linea alba (2 cm above and below the umbilicus). |
pre-intervention |
|
Primary |
Inter-recti distance |
Inter-recti distance will be measured by ultrasonography at rest, during abdominal draw-in and abdominal curl-up, at 2 locations on the linea alba (2 cm above and below the umbilicus). |
immediately post-intervention |
|
Primary |
Inter-recti distance |
Inter-recti distance will be measured by ultrasonography at rest, during abdominal draw-in and abdominal curl-up, at 2 locations on the linea alba (2 cm above and below the umbilicus). |
3-months follow-up |
|
Primary |
Abdominal and lumbar muscles thickness |
Transversus abdominis, obliquus internus, obliquus externus and multifidus thickness at rest and during draw-in will be measured by ultrasonography. |
pre-intervention |
|
Primary |
Abdominal and lumbar muscles thickness |
Transversus abdominis, obliquus internus, obliquus externus and multifidus thickness at rest and during draw-in will be measured by ultrasonography. |
immediately post-intervention |
|
Primary |
Abdominal and lumbar muscles thickness |
Transversus abdominis, obliquus internus, obliquus externus and multifidus thickness at rest and during draw-in will be measured by ultrasonography. |
3-months follow-up |
|
Secondary |
Lumbopelvic and abdominal pain |
Lumbopelvic and abdominal pain reported by the patient will be measured using a 100-mm visual analogue scale (VAS, 0-100, 0=minimum score, 100=maximum score). Lower values represent a better outcome (less pain). |
pre-intervention |
|
Secondary |
Lumbopelvic and abdominal pain |
Lumbopelvic and abdominal pain reported by the patient will be measured using a 100-mm visual analogue scale (VAS, 0-100, 0=minimum score, 100=maximum score). Lower values represent a better outcome (less pain). |
immediately post-intervention |
|
Secondary |
Lumbopelvic and abdominal pain |
Lumbopelvic and abdominal pain reported by the patient will be measured using a 100-mm visual analogue scale (VAS, 0-100, 0=minimum score, 100=maximum score). Lower values represent a better outcome (less pain). |
3-months follow-up |
|
Secondary |
Lumbopelvic and abdominal muscles function |
Lumbopelvic and abdominal muscles function will be tested with the supine bridge test, the prone bridge test and the lateral bridge test. |
pre-intervention |
|
Secondary |
Lumbopelvic and abdominal muscles function |
Lumbopelvic and abdominal muscles function will be tested with the supine bridge test, the prone bridge test and the lateral bridge test. |
immediately post-intervention |
|
Secondary |
Lumbopelvic and abdominal muscles function |
Lumbopelvic and abdominal muscles function will be tested with the supine bridge test, the prone bridge test and the lateral bridge test. |
3-months follow-up |
|
Secondary |
Lumbar disability |
Lumbar disability will be evaluated by the Oswestry Disability Index (ODI) |
pre-intervention |
|
Secondary |
Lumbar disability |
Lumbar disability will be evaluated by the Oswestry Disability Index (ODI) |
immediately post-intervention |
|
Secondary |
Lumbar disability |
Lumbar disability will be evaluated by the Oswestry Disability Index (ODI) |
3-months follow-up |
|
Secondary |
Severity of the urinary incontinence |
The severity of the urinary incontinence will be assessed using the Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-IU-SF) (0-21). |
pre-intervention |
|
Secondary |
Severity of the urinary incontinence |
The severity of the urinary incontinence will be assessed using the Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-IU-SF) (0-21). |
immediately post-intervention |
|
Secondary |
Severity of the urinary incontinence |
The severity of the urinary incontinence will be assessed using the Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-IU-SF) (0-21). |
3-months follow-up |
|
Secondary |
Sexual dysfunction |
Sexual dysfunction will be assessed using the 6-item Female Sexual Function Index (FSFI-6) (5-30). |
pre-intervention |
|
Secondary |
Sexual dysfunction |
Sexual dysfunction will be assessed using the 6-item Female Sexual Function Index (FSFI-6) (5-30). |
immediately post-intervention |
|
Secondary |
Sexual dysfunction |
Sexual dysfunction will be assessed using the 6-item Female Sexual Function Index (FSFI-6) (5-30). |
3-months follow-up |
|
Secondary |
Self-reported quality of life |
Self-reported quality of life will be evaluated with the Short Form-36 Health Survey (SF-36). In this scale, higher scores indicate higher quality of life. |
pre-intervention |
|
Secondary |
Self-reported quality of life |
Self-reported quality of life will be evaluated with the Short Form-36 Health Survey (SF-36). In this scale, higher scores indicate higher quality of life. |
immediately post-intervention |
|
Secondary |
Self-reported quality of life |
Self-reported quality of life will be evaluated with the Short Form-36 Health Survey (SF-36). In this scale, higher scores indicate higher quality of life. |
3-months follow-up |
|